Home > Insider Trading > Filing (0001127430-18-000050)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1104506	Insmed Inc	INSM	Pharmaceutical Preparations (2834)	541972729

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1401017	Nicole S Orlov Schaeffer	10 Finderne Avenue Building 10 Bridgewater NJ 08807	Chief People Strategy Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-05-29	11,584	$10.85	22,253	No	4	M	Direct
Common Stock	Disposition	2018-05-29	11,584	$27.68	10,669	No	4	S	Direct
Common Stock	Acquisiton	2018-05-30	25,991	$10.85	36,660	No	4	M	Direct
Common Stock	Disposition	2018-05-30	25,991	$28.24	10,669	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-05-29	11,584	$0.00	11,584	$10.85
Common Stock	Stock Option (right to buy)	Disposition	2018-05-30	25,991	$0.00	25,991	$10.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
63,566		2026-05-19	No	4	M	Direct
37,575		2026-05-19	No	4	M	Direct

Footnotes

This is the weighted average sales price representing 11,584 shares sold at prices ranging from $27.60 to $27.84 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
This is the weighted average sales price representing 25,991 shares sold at prices ranging from $28.00 to $28.32 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one-half percent (12.5%) vest on the six month anniversary of the first anniversary date and each six month anniversary date thereafter through the fourth anniversary of the date of grant.